|
APH1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.825740E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52089999996929E-06 |
| Normal-vs-Stage2 |
1.020490E-02 |
| Normal-vs-Stage3 |
8.597800E-01 |
| Normal-vs-Stage4 |
3.875800E-01 |
| Stage1-vs-Stage2 |
4.694000E-01 |
| Stage1-vs-Stage3 |
3.277600E-03 |
| Stage1-vs-Stage4 |
3.567400E-01 |
| Stage2-vs-Stage3 |
1.129810E-01 |
| Stage2-vs-Stage4 |
7.740200E-01 |
| Stage3-vs-Stage4 |
4.648600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.431510E-04 |
| Normal-vs-AfricanAmerican |
4.598100E-03 |
| Normal-vs-Asian |
5.023600E-01 |
| Caucasian-vs-AfricanAmerican |
8.188800E-01 |
| Caucasian-vs-Asian |
8.725200E-01 |
| AfricanAmerican-vs-Asian |
9.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09870000003709E-06 |
| Normal-vs-Female |
4.605800E-01 |
| Male-vs-Female |
3.033800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.252400E-02 |
| Normal-vs-Extreme_Weight |
6.06309999984234E-07 |
| Normal-vs-Obese |
9.544000E-03 |
| Normal-vs-Extreme_Obese |
7.842700E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.047800E-02 |
| Normal_Weight-vs-Obese |
6.330400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.882200E-01 |
| Extreme_Weight-vs-Obese |
5.040200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.084600E-01 |
| Obese-vs-Extreme_Obese |
5.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.557400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.517140E-03 |
| Normal-vs-Age(61-80Yrs) |
8.14470000000123E-05 |
| Normal-vs-Age(81-100Yrs) |
1.839690E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.287800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.683900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.342400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.821800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.965700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.455400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85220000004094E-06 |
| Normal-VS-Type2 PRCC |
3.053700E-02 |
| Normal-VS-KIRP CIMP |
6.382800E-01 |
| Normal-VS-Unclassified PRCC |
1.315650E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.068300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.563900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.556200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.358840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.806600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.911390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.383800E-04 |
| Normal-vs-N1 |
7.691400E-01 |
| Normal-vs-N2 |
2.958600E-01 |
| N0-vs-N1 |
3.806000E-02 |
| N0-vs-N2 |
4.323500E-03 |
| N1-vs-N2 |
3.634800E-01 |
|
|
